Both CD163 and Siglec1 (also known as CD169) are markers of M2 macrophages, in our study, only Cd163 was downregulated in mice with NASH, regardless of anti-IL-1β treatment (Fig. 4C). This evidence concerns the gene SIGLEC1 and metabolic dysfunction-associated steatohepatitis.